| Related Knowledge Base Chapters|
| Journal Articles|
|Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons|
Rotger M, Glass TR, Junier T, et al; MAGNIFICENT Consortium; INSIGHT; Swiss HIV Cohort Study. Clin Infect Dis. 2013 Jul;57(1):112-21.
|HIV infection and the risk of acute myocardial infarction|
Freiberg MS, Chang CC, Kuller LH, et al. JAMA Intern Med. 2013 Apr 22;173(8):614-22.
|HIV and coronary heart disease: time for a better understanding|
Boccara F, Lang S, Meuleman C, Ederhy S, et al. J Am Coll Cardiol. 2013 Feb 5;61(5):511-23. Review.
|Provider compliance with guidelines for management of cardiovascular risk in HIV-infected patients|
Lichtenstein KA, Armon C, Buchacz K, et al; HOPS Investigators. Prev Chronic Dis. 2013 Jan;10:E10.
|Relative risk of cardiovascular disease among people living with HIV: a systematic review and meta-analysis|
Islam FM, Wu J, Jansson J, et al. HIV Med. 2012 Sep;13(8):453-68. Review.
|Population-based study of risk factors for coronary heart disease among HIV-infected persons|
Oh JY, Greene K, He H, et al. Open AIDS J. 2012;6:177-80.
|HAART to heart: highly active antiretroviral therapy and the risk of cardiovascular disease in HIV-infected or exposed children and adults|
Lipshultz SE, Mas CM, Henkel JM, et al. Expert Rev Anti Infect Ther. 2012 Jun;10(6):661-74. Review.
|Cardiovascular risk estimation in 2012: lessons learned and applicability to the HIV population|
D'Agostino RB Sr. J Infect Dis. 2012 Jun;205 Suppl 3:S362-7. Review.
|HIV infection and coronary heart disease: an intersection of epidemics|
Triant VA. J Infect Dis. 2012 Jun;205 Suppl 3:S355-61. Review.
|Acute coronary syndromes in human immunodeficiency virus patients: a meta-analysis investigating adverse event rates and the role of antiretroviral therapy|
D'Ascenzo F, Cerrato E, Biondi-Zoccai G, et al. Eur Heart J. 2012 Apr;33(7):875-80. Review.
|Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study)|
Worm SW, De Wit S, Weber R, et at. Circulation. 2009 Feb 17;119(6):805-11.
| Guidelines and Best Practices|
|Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes|
Nathan DM, Buse JB, Davidson MB, et al. Diabetologia. 2009 Jan;52(1):17-30.
|Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).|
National Cholesterol Education Program, National Heart, Lung, and Blood Institute, National Institutes of Health. NIH Publication No. 02-5215. September 2002.
|Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention.|
Rosendorff C, Black HR, Cannon CP, et al. Circulation. 2007 May 29;115(21):2761-88.
| Conference Reports and Proceedings|
| Presentations, Interviews, and Roundtable Discussions|
| Online Books and Chapters|
| Clinician Support Tools|
| Patient and Community Education|
Funded by the National Heart, Lung, and Blood Institute to foster collaborative research into the mechanisms of HIV infection and ART and their relationship to cardiovascular disease risk.